Register Login

UNITED THERAPEUTICS CORP (UTHR)

Thompson Tommy G 🟡 adjusted position in 2.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $540.17 ($1.5M) Transaction Date: Mar 26, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot March 26, 2026, 8:35 p.m.

    🔍 Thompson Tommy G (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2026-03-26

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 1
    • Holdings reported: 2
    • Total shares acquired: 2,000
    • Total shares sold: 4,000
    • Total shares held: 14,000

    Detailed Transactions and Holdings:

    • Acquired 2,000 shares of Common Stock at $101.8 per share (Direct)
      Date: 2026-03-26 | Code: M | equity_swap_involved: false | shares_owned_after: 10,480.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 275 shares of Common Stock at $537.6192 per share (Direct)
      Date: 2026-03-26 | Code: S | equity_swap_involved: false | shares_owned_after: 10,205.00 | transaction_form_type: 4 | Footnotes: F2, F1
    • Sold 1,414 shares of Common Stock at $539.2451 per share (Direct)
      Date: 2026-03-26 | Code: S | equity_swap_involved: false | shares_owned_after: 8,791.00 | transaction_form_type: 4 | Footnotes: F3, F1
    • Sold 311 shares of Common Stock at $540.175 per share (Direct)
      Date: 2026-03-26 | Code: S | equity_swap_involved: false | shares_owned_after: 8,480.00 | transaction_form_type: 4 | Footnotes: F4, F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-26 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,200.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-26 | Code: H | nature_of_ownership: by Family LLC | shares_owned_after: 5,800.00
    • Sold 2,000 shares of Stock Option at $101.8 per share (Derivative)
      Date: 2026-03-26 | Code: M | Expires: 2026-06-21 | Exercise: 2017-06-21 | equity_swap_involved: false | transaction_form_type: 4

    Footnotes:

    • F1: Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
    • F2: This transaction was executed in multiple trades at prices ranging from $537.43 to $538.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F3: This transaction was executed in multiple trades at prices ranging from $538.63 to $539.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F4: This transaction was executed in multiple trades at prices ranging from $539.64 to $540.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Search

News categories